224 related articles for article (PubMed ID: 23118778)
1. Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.
Huang WC; Lin JY; Wallace CG; Wei FC; Liao SK
Clin Dev Immunol; 2012; 2012():107901. PubMed ID: 23118778
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
3. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments.
Leonard DA; McGrouther DA; Kurtz JM; Cetrulo CL
Clin Dev Immunol; 2012; 2012():863264. PubMed ID: 23320020
[TBL] [Abstract][Full Text] [Related]
5. Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine.
Mathes DW; Solari MG; Gazelle GS; Butler PE; Wu A; Nazzal A; Nielsen GP; Huang CA; Sachs DH; Lee WP; Randolph MA
Transpl Int; 2014 Oct; 27(10):1086-96. PubMed ID: 24963743
[TBL] [Abstract][Full Text] [Related]
6. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
Chimerism; 2013; 4(1):20-2. PubMed ID: 23712382
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction: hematopoietic chimerism.
Kawai T; Sachs DH
Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
[TBL] [Abstract][Full Text] [Related]
10. Mixed chimerism.
Sykes M; Sachs DH
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):707-26. PubMed ID: 11375074
[TBL] [Abstract][Full Text] [Related]
11. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
Foster RD; Pham S; Li S; Aitouche A
Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
[TBL] [Abstract][Full Text] [Related]
12. Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application?
Cetrulo CL; Drijkoningen T; Sachs DH
Curr Opin Organ Transplant; 2015 Dec; 20(6):602-7. PubMed ID: 26536420
[TBL] [Abstract][Full Text] [Related]
13. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
[TBL] [Abstract][Full Text] [Related]
14. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
15. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
16. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
17. Vascularized composite allograft tolerance across MHC barriers in a large animal model.
Leonard DA; Kurtz JM; Mallard C; Albritton A; Duran-Struuck R; Farkash EA; Crepeau R; Matar A; Horner BM; Randolph MA; Sachs DH; Huang CA; Cetrulo CL
Am J Transplant; 2014 Feb; 14(2):343-55. PubMed ID: 24405666
[TBL] [Abstract][Full Text] [Related]
18. Tolerance of a Vascularized Composite Allograft Achieved in MHC Class-I-mismatch Swine
Lellouch AG; Andrews AR; Saviane G; Ng ZY; Schol IM; Goutard M; Gama AR; Rosales IA; Colvin RB; Lantieri LA; Randolph MA; Benichou G; Cetrulo CL
Front Immunol; 2022; 13():829406. PubMed ID: 35619720
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.
Seung E; Mordes JP; Rossini AA; Greiner DL
J Clin Invest; 2003 Sep; 112(5):795-808. PubMed ID: 12952928
[TBL] [Abstract][Full Text] [Related]
20. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
